These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 2092446)

  • 21. Oxaliplatin (Eloxatin) for advanced colon cancer.
    Med Lett Drugs Ther; 2003 Jan; 45(1148):7-8. PubMed ID: 12571541
    [No Abstract]   [Full Text] [Related]  

  • 22. [New hormones and cytostatic drugs in tumor therapy].
    Lüftner D; Possinger K
    Internist (Berl); 1997 Nov; 38(11):1037-44. PubMed ID: 9453951
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of bladder cancer with cytostatic agents].
    Steineck G; Wijkström H; Borghede G
    Lakartidningen; 1994 Feb; 91(5):397-404. PubMed ID: 8114569
    [No Abstract]   [Full Text] [Related]  

  • 24. Navelbine: a new step in cancer therapy?
    Armand JP; Marty M
    Semin Oncol; 1989 Apr; 16(2 Suppl 4):41-5. PubMed ID: 2652319
    [No Abstract]   [Full Text] [Related]  

  • 25. Type II chemotherapy-related cardiac dysfunction: time to recognize a new entity.
    Ewer MS; Lippman SM
    J Clin Oncol; 2005 May; 23(13):2900-2. PubMed ID: 15860848
    [No Abstract]   [Full Text] [Related]  

  • 26. Influence of oxaliplatin on 5-fluorouracil plasma clearance and clinical consequences.
    Boisdron-Celle M; Craipeau C; Brienza S; Delva R; Guérin-Meyer V; Cvitkovic E; Gamelin E
    Cancer Chemother Pharmacol; 2002 Mar; 49(3):235-43. PubMed ID: 11935216
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Adjuvant systemic therapy of breast carcinoma].
    Wickramanayake PD; Katay I; Josting A; Diehl V
    Med Klin (Munich); 1996 Oct; 91(10):646-53. PubMed ID: 9019642
    [No Abstract]   [Full Text] [Related]  

  • 28. Palliative chemotherapy and hormonal therapy.
    Romond EH; Metcalfe MS; Macdonald JS
    Semin Oncol; 1985 Dec; 12(4):384-9. PubMed ID: 2417323
    [No Abstract]   [Full Text] [Related]  

  • 29. Leukemogenic risk prediction of the cytostatic treatment.
    Raposa T; Varkonyi J
    Prog Clin Biol Res; 1990; 340D():53-63. PubMed ID: 2196584
    [No Abstract]   [Full Text] [Related]  

  • 30. Evaluation of two dose individualisation methods for carboplatin.
    Desoize B; Dufour R; Urien S; Kaltenbach M; Colin P
    Anticancer Res; 1996; 16(4A):2073-8. PubMed ID: 8712745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-dose chemotherapy.
    Selby P
    Chemioterapia; 1987 Jun; 6(2 Suppl):675-7. PubMed ID: 3334660
    [No Abstract]   [Full Text] [Related]  

  • 32. Current status of chemotherapy in metastatic pancreatic cancer.
    Wils JA
    Anticancer Res; 1989; 9(4):1027-31. PubMed ID: 2683988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safer cancer chemotherapy using a kinetically based experimental approach.
    Price LA; Hill BT
    Mt Sinai J Med; 1985 Jun; 52(6):452-9. PubMed ID: 3875025
    [No Abstract]   [Full Text] [Related]  

  • 34. The medical management of malignant disease.
    Smith I
    Trans Med Soc Lond; 1986-1987; 103():18-20. PubMed ID: 2472030
    [No Abstract]   [Full Text] [Related]  

  • 35. Cancer chemotherapy.
    Med Lett Drugs Ther; 1987 Mar; 29(736):29-36. PubMed ID: 3561322
    [No Abstract]   [Full Text] [Related]  

  • 36. [Dose individualization for carboplatin in cancer chemotherapy].
    Oudard S; Lauraine EP
    Bull Cancer; 1997 Jun; 84(6):675-7. PubMed ID: 9295872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvant chemotherapy for colorectal cancer.
    Kerr DJ; Gray R
    Br J Hosp Med; 1996 Mar 6-19; 55(5):259-62. PubMed ID: 8777517
    [No Abstract]   [Full Text] [Related]  

  • 38. [Adjuvant therapeutic procedures in colorectal cancer: indications and possibilities].
    Porschen R; Bermann A
    Z Gastroenterol; 1993 Nov; 31 Suppl 5():35-8. PubMed ID: 8197798
    [No Abstract]   [Full Text] [Related]  

  • 39. [Chemotherapy of bladder carcinoma. Current status and trends].
    Block T
    Urologe A; 1994 Nov; 33(6):557-67. PubMed ID: 7817457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Characteristics of the occurrence of hematotoxic side effects of cytostatic drugs--results of a retrospective 10 year study of a district hospital].
    Radke EU; Papke J; Michel G; Hübler A; Mustafa K; Martin K; Eichelroth E
    Z Gesamte Inn Med; 1990 Apr; 45(8):214-8. PubMed ID: 2378133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.